<div id="readability-page-1"><p>Conning Inc. reduced its holdings in  Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 16.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,937 shares of the medical research company's stock after selling 2,195 shares during the period. Conning Inc.'s holdings in Thermo Fisher Scientific were worth $5,305,000 at the end of the most recent reporting period.</p><ul><li>Sector Rotation: 2 Smart Money Moves for 2026</li></ul><p>A number of other hedge funds and other institutional investors have also modified their holdings of the stock. TIAA Trust National Association boosted its holdings in shares of  Thermo Fisher Scientific by 10.5% during the second quarter. TIAA Trust National Association now owns 123,948 shares of the medical research company's stock worth $50,256,000 after acquiring an additional 11,817 shares during the period.  Lombard Odier Asset Management Switzerland SA boosted its stake in  Thermo Fisher Scientific by 8.4% in the 2nd quarter. Lombard Odier Asset Management Switzerland SA now owns 14,490 shares of the medical research company's stock valued at $5,875,000 after purchasing an additional 1,128 shares during the period.  Caledonia Investments PLC grew its holdings in  Thermo Fisher Scientific by 11.5% in the 2nd quarter. Caledonia Investments PLC now owns 111,767 shares of the medical research company's stock valued at $45,299,000 after buying an additional 11,500 shares in the last quarter.  Weaver Capital Management LLC acquired a new stake in shares of  Thermo Fisher Scientific during the third quarter worth $506,000.  Finally, Heritage Investors Management Corp boosted its position in shares of  Thermo Fisher Scientific by 9.6% in the second quarter. Heritage Investors Management Corp now owns 56,587 shares of the medical research company's stock valued at $22,944,000 after acquiring an additional 4,971 shares during the period. Institutional investors and hedge funds own  89.23% of the company's stock. </p><h2>Thermo Fisher Scientific Stock Up 2.3%</h2><p>Shares of NYSE TMO opened at $620.97 on Thursday. The stock has a 50-day moving average price of $584.24 and a two-hundred day moving average price of $521.63. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $628.08. The company has a current ratio of 1.50, a quick ratio of 1.11 and a debt-to-equity ratio of 0.62. The company has a market cap of $233.30 billion, a price-to-earnings ratio of 35.87, a PEG ratio of 3.99 and a beta of 0.91. </p><ul><li>Institutions Love These 3 Companies, Should You As Well?</li></ul><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings results on Wednesday, October 22nd. The medical research company reported $5.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.50 by $0.29. The company had revenue of $11.12 billion for the quarter, compared to analyst estimates of $10.90 billion. Thermo Fisher Scientific had a net margin of 15.02% and a return on equity of 16.97%. The firm's revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $5.28 EPS. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS.  As a group, analysts forecast that  Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year. </p><p>Thermo Fisher Scientific announced that its board has authorized a share repurchase plan on Thursday, November 6th that permits the company to buyback $5.00 billion in    shares. This buyback authorization permits the medical research company to reacquire up to 2.4% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board believes its stock is undervalued. </p><h2>Thermo Fisher Scientific Announces Dividend</h2><ul><li>These 3 Stocks Are Using Buybacks to Signal Market Confidence</li></ul><p>The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Monday, December 15th will be given a dividend of $0.43 per share. The ex-dividend date is Monday, December 15th. This represents a $1.72 dividend on an annualized basis and a yield of 0.3%. Thermo Fisher Scientific's payout ratio is currently 9.94%. </p><h2>Insiders Place Their Bets</h2><p>In other Thermo Fisher Scientific news, COO Michel Lagarde sold 32,000 shares of the stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $583.39, for a total value of $18,668,480.00. Following the completion of the transaction, the chief operating officer directly owned 65,480 shares in the company, valued at approximately $38,200,377.20. This trade represents a 32.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, VP Lisa P. Britt sold 10,225 shares of the business's stock in a transaction dated Friday, November 7th. The stock was sold at an average price of $571.62, for a total value of $5,844,814.50. Following the sale, the vice president owned 14,145 shares in the company, valued at approximately $8,085,564.90. This trade represents a 41.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 149,271 shares of company stock worth $86,507,282. Company insiders own  0.33% of the company's stock. </p><h2>Wall Street Analyst Weigh In</h2><p>Several brokerages have weighed in on TMO. Hsbc Global Res upgraded shares of Thermo Fisher Scientific from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Monday, December 1st. Citigroup upgraded shares of Thermo Fisher Scientific from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and lifted their price target for the company from $580.00 to $660.00 in a research report on Thursday, December 11th. Deutsche Bank Aktiengesellschaft  restated a &#34;buy&#34; rating on shares of Thermo Fisher Scientific in a research note on Thursday, October 23rd. UBS Group upped their target price on Thermo Fisher Scientific from $500.00 to $590.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, October 23rd. Finally, The Goldman Sachs Group started coverage on Thermo Fisher Scientific in a research note on Tuesday, December 9th. They issued a &#34;buy&#34; rating and a $685.00 price target for the company. One analyst  has rated the stock with a Strong Buy rating, nineteen have assigned  a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $625.47.</p><p><b>Get Our Latest Stock Report on Thermo Fisher Scientific</b></p><h2>About Thermo Fisher Scientific</h2> (Free Report)<p>Thermo Fisher Scientific <span>NYSE: TMO<span></span></span> is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.  </p><p>Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Thermo Fisher Scientific</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>A U.S. “birthright” claim worth trillions - activated quietly</li><li>Executive Order 14330: Trump’s Biggest Yet</li><li>If You Keep Cash In A U.S. Bank Account… Read This NOW</li></ul><p><strong>Want to see what other hedge funds are holding TMO?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Conning Inc. has reduced its stake in Thermo Fisher Scientific Inc. by 16.7%, now holding 10,937 shares valued at approximately $5.31 million. Other institutional investors have also adjusted their holdings, with TIAA Trust National Association increasing its stake by 10.5%. Thermo Fisher's stock recently rose 2.3%, trading at $620.97, and the company reported a quarterly EPS of $5.79, exceeding estimates. Additionally, Thermo Fisher announced a $5 billion share repurchase plan and a quarterly dividend of $0.43 per share, reflecting confidence in its stock value.</p>

Conning Inc. Has $5.31 Million Stake in Thermo Fisher Scientific Inc. $TMO